Papers on pembrolizumab

5 papers

Thursday, January 29

Polish Archives of Internal MedicineJan 29

Drug-induced hyponatremia associated with sodium-glucose cotransporter 2 inhibitors, immune checkpoint inhibitors, and targeted anticancer agents

ReviewmTOR inhibitors

Sunday, February 26

BiologyFeb 26

Impact of Frailty on Outcomes of First-Line Pembrolizumab Monotherapy in a Real-World Population with Advanced Non-Small Cell Lung Cancer

Cohort study of 101 peopleNon-small cell lung cancer

Friday, February 3

Cancer MedicineFeb 3

Association between PD-1 inhibitor-related adverse events and frailty assessed by frailty index in lung cancer patients

Cohort study of 114 peopleFrailty index

Tuesday, August 3

Aging and CancerAug 3

Impact of age-related T cell dynamics on the identification of biomarkers predictive of immunotherapy discontinuation: a prospective cohort study

Cohort study in peopleBiomarkers

Thursday, May 7

PreprintMay 7

Timing of immune checkpoint inhibitors for metastatic patients over 75 years of age: the earlier the better

Preprint: meta-analysis of randomized trialsImmune checkpoint inhibitors